Personalized Ultrasonic Brain Stimulation for Fibromyalgia
Part of paid clinical trials in Salt Lake City, Utah.
- Sponsor
- University of Utah
- Study ID
- NCT07361328
- Status
- Recruiting
Conditions
- Fibromyalgia (FM)
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- Low-intensity ultrasound brain stimulation — DEVICEThe device is called BEAM, which looks like an oversized pair of goggles that can be fitted over a participant's head. Once fastened, it emits a low-intensity ultrasound wave from your temples that targets a specific area of the brain. The treatment lasts about 45 minutes per session. In this study, participants will undergo a total of 6 sessions within a period of 2 weeks.
- Sham (No Treatment) — DEVICEThere will be no ultrasound stimulation delivered
Study Details
The primary purpose of this research is to evaluate a new kind of noninvasive brain stimulation intervention using the investigational ultrasound device, which might be useful for treating fibromyalgia. The device is for investigational use only and is not yet approved by the FDA for the intended use. * Participants will be asked to visit the study center 7 times for in-person assessment and treatment sessions. In addition, participants will be asked to complete an online assessment 7 times. During in-person or online visits: * Participants will undergo an MRI scan twice during the first and last in-person visit (1 hour each) The second MRI may be optional. * There will be 6 treatment sessions (45 minutes each) within a 2-week period * The online assessment occurs (15 minutes each) * two consecutive days before the first treatment session * 15 days after the first treatment session * 22 days after the first treatment session * 29 days after the first treatment session * 44 days after the first treatment session * 60 days after the first treatment session
Key Dates
- Start date
- Jan 5, 2026
- Status verified
- Jan 2026
- Primary completion
- Dec 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Ultrasound GroupParticipants in this group will receive low-intensity ultrasound brain stimulation
- Sham Comparator: Sham controlParticipants in this group will undergo the same procedure with the Ultrasound group but do not receive ultrasound stimulation
Primary Outcome Measure
Numerical Rating Scale Pain +15days. 0 (no pain) - 10 (worst pain) [ Time Frame: 15 days after the first treatment ]
Central Contacts
- Madison Bunnell, Research Study coordinator385-209-1070
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Pain Research Center, University of Utah | Salt Lake City | Utah | 84108 | - |
Find similar trials in Salt Lake City, UT
Related Studies
- Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET)Recruiting · University of Utah · Salt Lake City, Utah
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruiting · Brain Inflammation Collaborative · Delafield, Wisconsin
- Dose Response of Exercise for Arthritis ManagementRecruiting · University of South Carolina · Columbia, South Carolina
- Investigating the Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on the Brain in People With FibromyalgiaNot Yet Recruiting · University of Rochester · Rochester, New York